Sono Tek earnings release, July 8, 2026

Sono Tek Corp (SOTK) · Form 8-K, Item 2.02 · Filed · SEC filing

Sono-Tek Corporation Reports First Quarter Fiscal 2027

Results

Revenue Increased 10%; Gross Margin Expanded to 57%;

Operating Income Increased 86%; Net Income Increased 67%

Anticipating Continued Revenue Growth in 1H 2027 Driven by Strong Medical Sector and Higher Value Production Systems

MILTON, N.Y., July 8, 2026 – Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of precision ultrasonic coating systems, today reported financial results for the first quarter of fiscal 2027, ended May 31, 2026.

First Quarter Fiscal 2027 Highlights

Net sales increased 10% to $5.66 million

Gross margin expanded to 57% from 52%

Gross profit increased 21% to $3.21 million

Operating income increased 86% to $897,000

Net income increased 53% to $741,000, or $0.05 per diluted share

Cash, cash equivalents, and marketable securities increased to $16.65 million with no debt

Backlog increased to approximately $7.73 million

Steve Harshbarger, CEO & President of Sono-Tek, stated:

"Fiscal 2027 is off to a strong start with double-digit revenue growth, meaningful margin expansion, and improved profitability, reflecting disciplined execution across our operations and the continued success of our strategy of focusing on higher-value production systems in advanced technology markets, particularly medical devices.

"Our medical business was the primary growth driver this quarter, with strong demand for specialty stent coating systems and Drug-Eluting Balloon platforms across the U.S., Europe, and Asia. This exceptional mix of business-including a higher concentration of medical systems, shipments of higher-value production platforms, and a greater proportion of U.S. based sales with lower distributor commission expenses, was a significant contributor to our gross margin expansion. While we are very pleased with these results, product mix, geographic mix, and shipment timing naturally fluctuate from quarter to quarter, and we would not expect this level of gross margin to be representative of every future quarter. Our technology is increasingly being selected for applications requiring highly controlled, repeatable thin-film coatings, positioning Sono-Tek to benefit as manufacturing precision requirements continue to increase across multiple industries.

"Looking ahead, we remain focused on expanding our installed base of production systems, supporting customers as they scale from development into commercial manufacturing, and investing in the engineering and commercial capabilities that will drive our next phase of growth. The Company continues to project revenue growth during the first half of fiscal 2027, supported by strong medical demand and continued shipments of higher-value production systems, and we maintain our previously communicated expectation of flat to modest revenue growth for the full fiscal year. This full-year outlook primarily reflects the timing of several large production platform orders. As these higher-value production systems become a larger portion of our business, quarterly revenue may increasingly be influenced by shipment timing. Our strong balance sheet provides the flexibility to execute these priorities while continuing to create long-term value for shareholders."

Dr. Christopher L. Coccio, Executive Chairman, added:

"Our first quarter results reinforce the long-term strength of Sono-Tek's ultrasonic coating technology platform and validate the strategic direction that we have pursued for many years. As precision manufacturing requirements continue to increase across advanced industries, we believe we are well positioned to expand our leadership through continued innovation and differentiated application expertise.

"We have spent decades building differentiated technology, deep application expertise, and lasting customer relationships that continue to position us for future success. We believe these enduring strengths, together with disciplined investment and a strong financial foundation, position Sono-Tek to capitalize on attractive long-term growth opportunities while creating lasting shareholder value."

First Quarter Fiscal 2027 Results

Net sales increased 10% to $5.66 million, driven by strong

Medical demand, partially offset by lower Alternative Energy shipments compared with the prior-year period.

Gross profit increased 21% to $3.21 million, with gross margin expanding from 52% to 57% due to favorable product mix and higher-value system shipments.

Operating expenses increased 6% to $2.32 million due to continued investment in sales, engineering, and business development initiatives.

Operating income increased 86% to $897,000.

Net income increased 53% to $741,000, or $0.05 per diluted share.

First Quarter Fiscal 2027 Results – (compared with the prior year period)

First Quarter Fiscal 2027 Product and Market Highlights

Market Sales

Medical: $3.95 million vs. $809,000

Electronics/Microelectronics: $863,000 vs. $943,000

Alternative Energy/Clean: $319,000 vs. $3.25 million

Industrial: $530,000 vs. $119,000

Emerging R&D and Other: $3,000 vs. $14,000

Medical growth was driven by specialty stent coating systems in the U.S. and Drug-Eluting Balloon platforms across the U.S., China, and Europe. Alternative Energy declined due to reduced electrolysis demand and the absence of solar shipments. Industrial growth reflected system upgrades and R&D nano-coating applications.

Product Sales

Fluxing Systems: $92,000 vs. $152,000

In-Line Coating Systems: $2.16 million vs. $3.05 million

Multi-Axis Coating Systems: $2.08 million vs. $677,000

OEM Systems: $231,000 vs. $130,000

Spare Parts, Services and Other: $1.10 million vs. $1.12 million

Total Net Sales: $5.66 million vs. $5.13 million

Multi-Axis growth was driven by strong demand across multiple end markets. In-Line declined due to reduced clean energy shipments, including the absence of prior-year solar system deliveries. OEM... (truncreased on semiconductor and fluxer OEM demand, while services remained stable.

Balance Sheet, Backlog and Outlook

Balance Sheet

: Cash, cash equivalents, and marketable securities totaled $16.65 million, compared with $14.81 million at the prior year end. The Company had no outstanding debt.

Backlog

: Combined equipment and service-related backlog at May 31, 2026 was $7.73 million, compared to backlog of $7.48 million at May 31, 2025, an increase of $250,000, or 3%. Backlog was down $1.39 million compared to the fiscal 2026 year-end level of $9.12 million.

Outlook:

Sono-Tek anticipates continued revenue growth and profitability in the first half of fiscal year 2027 compared to the first half of fiscal year 2026, driven by expanding demand in the medical sector and continued adoption of high value production-scale coating systems across multiple end markets. Total fiscal year 2027 revenue is currently projected to be relatively flat to modestly higher compared to fiscal year 2026, as visibility beyond the first half remains limited due to continued uncertainty in certain clean energy sectors and the timing of shipments for higher value production scale platforms.

About Sono-Tek

Sono-Tek Corporation is a global leader in the design and manufacture of ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems are used to apply thin films onto parts used in diverse industries including microelectronics, alternative energy, medical devices, advanced industrial manufacturing, and research and development sectors worldwide. Sono-Tek's inroads into the clean energy sector have shown transformative results in next-gen solar cells, fuel cells, green hydrogen generation, and carbon capture applications.

Our product line is rapidly evolving, transitioning from R&D to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Our comprehensive suite of thin film coating solutions and application consulting services are expected to generate unparalleled results for our clients and help some of the world's most promising companies achieve technological breakthroughs and bring them to the market. We strategically deliver our products to customers through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.

Our solutions are environmentally friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for our customers’ products and processes. For further information, visit www.sono-tek.com

Safe Harbor Statement

Financial statements

Income Statement

Three Months Ended May 31, — – (compared with the prior year period)

Three Months Ended May 31, – 2026Three Months Ended May 31, – 2025Change – $$Change – %
Net Sales5,661,0005,133,000528,00010.0%
Gross Profit3,214,0002,665,000549,00021.0%
Gross Margin57.0%52.0%
Operating Income897,000483,000414,00086.0%
Operating Margin16.0%9.0%
Net Income741,000485,000256,00053.0%
Net Margin13.0%9.0%
Basic Earnings Per Share0.050.03
Diluted Earnings Per Share0.050.03
Weighted Average Shares -Basic15,713,00015,734,000
Weighted Average Shares - Diluted15,737,00015,749,000

Income Statement

Three Months Ended May 31, — (Unaudited)

Three Months Ended May 31, – 2026Three Months Ended May 31, – 2025
Net Sales5,661,1595,132,773
Cost of Goods Sold2,447,2412,468,259
Gross Profit3,213,9182,664,514
Operating ExpensesResearch and product development costs616,982668,470
Operating ExpensesMarketing and selling expenses1,024,984858,151
Operating ExpensesGeneral and administrative costs674,792654,525
Operating ExpensesTotal Operating Expenses2,316,7582,181,146
Operating ExpensesOperating Income897,160483,368
Operating ExpensesInterest and Dividend Income114,624142,098
Operating ExpensesNet unrealized (loss) on marketable securities-26,271-21,923
Operating ExpensesIncome Before Income Taxes985,513603,543
Operating ExpensesIncome Tax Expense244,345118,558
Operating ExpensesNet Income741,168484,985
Operating ExpensesBasic Earnings Per Share0.050.03
Operating ExpensesDiluted Earnings Per Share0.050.03
Operating ExpensesWeighted Average Shares - Basic15,713,18515,733,955
Operating ExpensesWeighted Average Shares - Diluted15,737,27615,748,556

Balance Sheet

May 31, 2026 — CONDENSED CONSOLIDATED BALANCE SHEETS

May 31, 2026 – (Unaudited)February 28, – 2026
Current Assets:Cash and cash equivalents8,982,0757,339,403
Current Assets:Marketable securities7,669,8727,469,649
Current Assets:Accounts receivable (less allowance of $12,225, respectively)1,264,9323,350,953
Current Assets:Inventories4,063,1323,923,350
Current Assets:Prepaid expenses and other current assets659,518743,295
Current Assets:Total current assets22,639,52922,826,650
Current Assets:Land250,000250,000
Current Assets:Buildings, equipment, furnishings and leasehold improvements, net2,138,2262,173,443
Current Assets:Intangible assets, net27,89229,791
Current Assets:Deferred tax asset809,1821,141,611
Current Assets:TOTAL ASSETS25,864,82926,421,495
Current Liabilities:Accounts payable935,4421,038,885
Current Liabilities:Accrued expenses2,088,2292,227,401
Current Liabilities:Customer deposits2,006,8963,069,743
Current Liabilities:Income taxes payable147,984255,398
Current Liabilities:Total current liabilities5,178,5516,591,427
Current Liabilities:Deferred tax liability75,23855,909
Current Liabilities:Total liabilities5,253,7896,647,336
Stockholders’ EquityCommon stock, $.01 par value; 25,000,000 shares authorized, 15,716,723 and 15,710,389 issued and outstanding as of May 31, 2026 and February 28, 2026157,167157,104
Stockholders’ EquityAdditional paid-in capital10,282,50810,186,858
Stockholders’ EquityAccumulated earnings10,171,3659,430,197
Stockholders’ EquityTotal stockholders’ equity20,611,04019,774,159
Stockholders’ EquityTOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY25,864,82926,421,495
Full release

This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These “forward-looking statements’ are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions, including political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; inflationary and supply chain pressures; continued strength of sales to the medical device and electronics markets; increased private and public funding for the clean energy sector; continued strong demand for Sono-Tek’s suite of thin film coating solutions and application consulting services in the clean energy and other markets; maintenance of order backlog; evolving tariff policies; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; timing of large orders and completion on schedule and on budget; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of first half and annual revenues and profitability within the forecasted ranges of guidance. We undertake no obligation to update any forward-looking statement.

For more information:

Sono-Tek Corp.

Stephen J. Bagley

Chief Financial Officer

Ph: (845) 795-2020 info@sono-tek.com

Investor Relations

Kirin Smith, President

PCG Advisory, Inc. ksmith@pcgadvisory.com

- Financial Tables to follow –

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Sono Tek earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.